IMMUNOMODULATORY RESPONSE TO NEOADJUVANT NIVOLUMAB IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA: RESULTS FROM A PHASE I TRIAL

被引：0
|
作者：
Singla, Nirmish
Nirschl, Thomas
Obradovic, Aleksandar
Shenderov, Eugene
Lombardo, Kara
Liu, Xiaopu
Pons, Alice
Zarif, Jelani
Rowe, Steven
Trock, Bruce
Hammers, Hans
Bivalacqua, Trinity
Pierorazio, Phillip
Deutsch, Julie
Lotan, Tamara
Taube, Janis
Ged, Yasser
Gorin, Michael
Allaf, Mohamad
Drake, Charles
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD43-05
引用
收藏
页码：E1119 / E1120
页数：2
相关论文
共 50 条
  • [31] Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease
    Wagener, Nina
    Edelmann, Dominic
    Benner, Axel
    Zigeuner, Richard
    Borgmann, Hendrik
    Wolff, Ingmar
    Krabbe, Laura M.
    Musquera, Mireia
    Dell'Oglio, Paolo
    Capitanio, Umberto
    Klatte, Tobias
    Cindolo, Luca
    May, Matthias
    Brookman-May, Sabine D.
    PLOS ONE, 2017, 12 (09):
  • [32] Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis
    Carlo, Maria I.
    Feldman, Darren R.
    EUROPEAN UROLOGY, 2016, 70 (06) : 1082 - 1083
  • [33] Nivolumab undergoing Phase I testing in metastatic renal cell carcinoma patients
    Nagda, Priti
    FUTURE ONCOLOGY, 2013, 9 (08) : 1070 - 1070
  • [34] Nivolumab undergoes Phase I testing in metastatic renal cell carcinoma patientslung
    不详
    IMMUNOTHERAPY, 2013, 5 (08) : 796 - 796
  • [35] Pseudoprogression: A case of metastatic renal clear cell carcinoma treated with nivolumab
    Tabei, Tadashi
    Tsuura, Yukio
    Kobayashi, Kazuki
    PATHOLOGY INTERNATIONAL, 2018, 68 (11) : 627 - 629
  • [36] Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates
    Lee, Chung-Han
    Voss, Martin H.
    Carlo, Maria Isabel
    Chen, Ying-Bei
    Zucker, Mark
    Knezevic, Andrea
    Lefkowitz, Robert A.
    Shapnik, Natalie
    Dadoun, Chloe
    Reznik, Ed
    Shah, Neil J.
    Owens, Colette Ngozi
    McHugh, Deaglan Joseph
    Aggen, David Henry
    Laccetti, Andrew Leonard
    Kotecha, Ritesh
    Feldman, Darren R.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2333 - +
  • [37] Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab
    Sauer, R.
    Kiewe, P.
    Desole, M.
    Schuler, M.
    Theissig, F.
    Roth, A.
    Mairinger, T.
    PATHOLOGE, 2017, 38 (06): : 535 - 539
  • [38] Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non- Clear Cell Renal Cell Carcinoma
    Gupta, Ruby
    Ornstein, Moshe Chaim
    Li, Hong
    Allman, Kimberly D.
    Wood, Laura S.
    Gilligan, Timothy
    Garcia, Jorge A.
    Von Merveldt, Dendra
    Hammers, Hans J.
    Rini, Brian I.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 429 - 435
  • [39] Intratumoral T-cell infiltration and response to nivolumab plus ipilimumab in patients with metastatic clear cell renal cell carcinoma from the CheckMate-214 trial
    Matar, Sayed
    Jegede, Opeyemi
    Denize, Thomas
    Ghandour, Fatme
    Laimon, Yasmin Nabil
    El Ahmar, Nourhan
    Sheshdeh, Aseman Bagheri
    Savla, Varunika
    Mohanna, Razan Assaad
    Catalano, Paul J.
    Braun, David A.
    Sun, Maxine
    Gupta, Saurabh
    Vemula, Sai Vikram
    Freeman, Gordon J.
    Motzer, Robert J.
    Atkins, Michael B.
    McDermott, David F.
    Choueiri, Toni K.
    Signoretti, Sabina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
    Zhang, Tian
    Pabla, Sarabjot
    Lenzo, Felicia L.
    Conroy, Jeffrey M.
    Nesline, Mary K.
    Glenn, Sean T.
    Papanicolau-Sengos, Antonios
    Burgher, Blake
    Giamo, Vincent
    Andreas, Jonathan
    Wang, Yirong
    Bshara, Wiam
    Madden, Katherine G.
    Shirai, Keisuke
    Dragnev, Konstantin
    Tafe, Laura J.
    Gupta, Rajan
    Zhu, Jason
    Labriola, Matthew
    McCall, Shannon
    George, Daniel J.
    Ghatalia, Pooja
    Dayyani, Farshid
    Edwards, Robert
    Park, Michelle S.
    Singh, Rajbir
    Jacob, Robin
    George, Saby
    Xu, Bo
    Zibelman, Matthew
    Kurzrock, Razelle
    Morrison, Carl
    ONCOIMMUNOLOGY, 2020, 9 (01):
12345